Peter Hjelmström is the Director/CEO of Uppsala Monitoring Centre (UMC). The UMC is a non-profit, self-funded foundation established in 1978 through an agreement between the World Health Organization (WHO) and the Government of Sweden to oversee the technical and scientific operations of the WHO Programme for International Drug Monitoring. Peter is physician and scientist, with MD and PhD degrees, and he did his postdoctoral fellowship at Yale University and was an associate professor at Karolinska Institutet before working in the pharmaceutical industry for 17 years. His most recent role before joining UMC was as Chief Medical Officer at a Swedish pharmaceutical company. He has published over 45 manuscripts in peer-reviewed scientific journals mainly within immunology and the pharmacoepidemiology of opioid dependence.